Dolly Parton’s Gifts in Song and Storytelling Arose From an Upbringing Steeped in the Ethic of Self-Reliance
By GEORGE WILL
|Loading article…
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
Published:
Updated:
Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any indication.
By GEORGE WILL
|
By ROSS ANDERSON
|
By JEFFREY WELLS
|
By MATTHEW RICE
|
By EMANUELE SCIMIA
|
By LUKE FUNK
|
By ALEX ZDAN
|
By MARIO NAVES
|Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any indication.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.